Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Class H (6990)
6990 · Health Care · 
China
Sichuan Kelun-Biotech Biopharmaceutical Co. Ltd. Class H (6990) is a Chinese company in the Health Care sector. The stock has its largest weight in XCS6 (MSCI China), at 0.15%. Anyone who holds an ETF containing Sichuan Kelun-Biotech Biopharmaceutical also has an indirect stake in the company.
Data and Charts: Sichuan Kelun-Biotech Biopharmaceutical
Key Data for Sichuan Kelun-Biotech Biopharmaceutical
Alysly Data Analysis: Sichuan Kelun-Biotech Biopharmaceutical
What ETF Is Sichuan Kelun-Biotech Biopharmaceutical In?
Sichuan Kelun-Biotech Biopharmaceutical has average ETF coverage and is held by 10 of the 104 ETFs we track, which together follow 5 indices. That puts the stock in more ETFs than 65.1% of the 4,341 stocks we track.
| ETF | Index | Weight | per €1,000 in the ETF |
|---|---|---|---|
| XCS6 / XCS7 | MSCI China | 0.15% | €1.54 |
| IS3N | MSCI EM IMI | 0.03% | €0.30 |
| XMME / XEMD | MSCI Emerging Markets | 0.03% | €0.30 |
| SPYM | MSCI Emerging Markets | 0.03% | €0.29 |
| SPYI / SPSA | MSCI ACWI IMI | < 0.01% | < €0.05 |
| SPYY | MSCI ACWI | < 0.01% | < €0.05 |
| IUSQ | MSCI ACWI | < 0.01% | < €0.05 |
The last column shows how much of €1,000 in one of these funds goes to Sichuan Kelun-Biotech Biopharmaceutical, based on each fund's latest holdings list.
US-listed ETFs holding Sichuan Kelun-Biotech Biopharmaceutical (weight per latest SEC filing): VXUS 0.01%. These funds are registered in the US; retail investors in the EU usually cannot buy them.
What's Inside Your ETF Portfolio and the ETF overlap check show how much Sichuan Kelun-Biotech Biopharmaceutical overlaps with the rest of a portfolio.
Stocks With ETF Exposure Similar to Sichuan Kelun-Biotech Biopharmaceutical
| Stock | Shared ETFs | r |
|---|---|---|
| Sichuan Kelun-Biotech Biopharmaceutical | – | – |
| CSPC Pharmaceutical Group Limited | 10 | – |
| Sinopharm Group | 10 | – |
| 3SBio | 10 | – |
| XtalPi Holdings Limited | 10 | – |
| BeOne Medicines | 10 | – |
| Akeso | 10 | – |
| RemeGen | 10 | – |
| Legend Biotech Corp. Sponsored | 10 | – |
These stocks reach a portfolio through largely the same funds as Sichuan Kelun-Biotech Biopharmaceutical. “Shared ETFs” counts the funds that hold both.
